HUM Stock Summary and Trading Ideas (Humana | NYSE:HUM)

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana trades on the NYSE stock market under the symbol HUM.

As of March 11, 2025, HUM stock price declined to $250.20 with 1,259,453 million shares trading.

HUM has a beta of 0.41, meaning it tends to be less sensitive to market movements. HUM has a correlation of 0.01 to the broad based SPY ETF.

HUM has a market cap of $30.19 billion. This is considered a Large Cap stock.

Last quarter Humana reported $29 billion in Revenue and -$2.16 earnings per share. This beat revenue expectation by $359 million and missed earnings estimates by -$.04.

In the last 3 years, HUM traded as high as $571.30 and as low as $213.31.

The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, VO, SPY, IVV.

HUM has underperformed the market in the last year with a return of -25.2%, while the SPY ETF gained +10.0%. In the last 3 month period, HUM fell short of the market, returning -12.2%, while SPY returned -7.5%. However, in the most recent 2 weeks HUM has outperformed the stock market by returning -1.9%, while SPY returned -6.9%.

HUM support price is $244.72 and resistance is $257.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM shares will trade within this expected range on the day.